Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 513b is a non-coding RNA (microRNA) involved in post-transcriptional regulation of gene expression, typically by binding to specific mRNAs and inhibiting their translation or promoting their degradation[3]. It has been studied as a regulator of cell proliferation and apoptosis, notably acting as a tumor suppressor in cancers such as retinoblastoma by targeting TRIB1 and inhibiting the AKT/mTOR signaling pathway; however, it may also act as an oncogene in other cancers (e.g., cervical and ovarian cancer), suggesting context-dependent functions[2]. MIR513B and its mature form miR-513b-5p are encoded on the X chromosome and may serve as biomarkers or putative therapeutic targets for several cancers and certain developmental conditions[2][3]. No direct drug interactions are currently reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 513b (miR-513b).